메뉴 건너뛰기




Volumn 30, Issue 4, 2011, Pages 320-322

Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse

Author keywords

Bevacizumab; Corneal neovascularization; Subconjunctival injection; Tetracaine abuse

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; TETRACAINE;

EID: 80455168331     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.573834     Document Type: Article
Times cited : (5)

References (11)
  • 1
    • 3042742329 scopus 로고    scopus 로고
    • Toxic keratopathy associated with abuse of low-dose anesthetic: A case report
    • Chen HT, Chen KH, Hsu WM. Toxic keratopathy associated with abuse of low-dose anesthetic: A case report. Cornea 2004;23: 527-529.
    • (2004) Cornea , vol.23 , pp. 527-529
    • Chen, H.T.1    Chen, K.H.2    Hsu, W.M.3
  • 4
    • 69549112893 scopus 로고    scopus 로고
    • Shortand long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization
    • Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C. Shortand long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2009;247:1375-1382.
    • (2009) Graefes Arch Clin Exp Ophthalmol , vol.247 , pp. 1375-1382
    • Koenig, Y.1    Bock, F.2    Horn, F.3    Kruse, F.4    Straub, K.5    Cursiefen, C.6
  • 8
    • 0033856243 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas
    • Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 2000;41:2514-2522. (Pubitemid 30624378)
    • (2000) Investigative Ophthalmology and Visual Science , vol.41 , Issue.9 , pp. 2514-2522
    • Philipp, W.1    Speicher, L.2    Humpel, C.3
  • 9
    • 34250315760 scopus 로고    scopus 로고
    • Topical bevacizumab therapy for corneal neovascularization
    • DOI 10.1001/archopht.125.6.834
    • DeStafeno JJ, Kim T. Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol 2007;125:834-836. (Pubitemid 46919748)
    • (2007) Archives of Ophthalmology , vol.125 , Issue.6 , pp. 834-836
    • DeStafeno, J.J.1    Kim, T.2
  • 10
    • 47949107165 scopus 로고    scopus 로고
    • Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis
    • Carrasco MA. Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis. Cornea 2008;27: 743-745.
    • (2008) Cornea , vol.27 , pp. 743-745
    • Carrasco, M.A.1
  • 11
    • 0037235464 scopus 로고    scopus 로고
    • Pericyte recruitment in human corneal angiogenesis: An ultrastructural study with clinicopathological correlation
    • DOI 10.1136/bjo.87.1.101
    • Cursiefen C, Hofmann-Rummelt C, Küchle M, Schlötzer-Schrehardt U. Pericyte recruitment in human corneal angiogenesis: An ultrastructural study with clinicopathological correlation. Br J Ophthalmol 2003;87:101-106. (Pubitemid 36071788)
    • (2003) British Journal of Ophthalmology , vol.87 , Issue.1 , pp. 101-106
    • Cursiefen, C.1    Hofmann-Rummelt, C.2    Kuchle, M.3    Schlotzer-Schrehardt, U.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.